Natalia Karpyshyn

Natalia Karpyshyn

Auto-generated profile, based on publicly available information

Natalia Karpyshyn

State Non-profit Society "Danylo Halytsky Lviv National Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018
Verified
Journal Article
Closed access
TMTetiana Maksymets
Tetiana Maksymets
NKNatalia Karpyshyn
Natalia Karpyshyn
TGTaras Gutor
Taras Gutor
HSHelen Sklyarova
Helen Sklyarova
ESEugen Sklyarov
Eugen Sklyarov

29 August 2026 in Ukrainian Journal of Nephrology and Dialysis
Verified
Journal Article
Open access
PDF file
HSHalyna Savuliak
Halyna Savuliak
Vladyslav BardashVladyslav Bardash
Vladyslav Bardash
TMTetiana Maksymets
Tetiana Maksymets
HKHalyna Kovalchuk
Halyna Kovalchuk
NKNatalia Karpyshyn
Natalia Karpyshyn
ESEugen Sklyarov
Eugen Sklyarov
Multiple myeloma (MM) is frequently complicated by renal impairment, but traditional markers like the estimated glomerular filtration rate (eGFR) are inherently late indicators that fail to capture early structural damage. We aimed to evaluate the combined prognostic value of neutrophil gelatinase-associated lipocalin (NGAL), a marker of tubular injury, and fibroblast growth factor-23 (FGF-23), a reflection of bone-mineral dysregulation and tumor burden, independently of eGFR and disease stage. Methods. This retrospective cohort study included 95 adult patients with a confirmed diagnosis of MM. Baseline serum NGAL and FGF-23 concentrations were quantified using enzyme-linked immunosorbent assays (ELISA). Optimal prognostic cutoffs were determined using maximally selected rank statistics. A composite risk score was constructed to compare patients with concurrent biomarker elevations (score 2) against those with zero or one elevated marker (score 0–1). Overall survival was assessed using Kaplan-Meier analysis and multivariable Cox proportional hazards regression models adjusted for eGFR and International Staging System (ISS) stage. Results. The optimal prognostic cutoffs were identified as 153.8 ng/mL for NGAL and 36.4 pg/mL for FGF-23. Patients with a composite score of 2 experienced significantly lower overall survival probabilities (log-rank p = 0.0071). In multivariable analysis, the composite risk score remained a potential independent prognostic marker for mortality after adjustment for baseline eGFR (adjusted HR = 6.32, 95% CI: 1.25–31.88, p = 0.025) and ISS stage (p = 0.0057). Conclusions. The combined assessment of serum NGAL and FGF-23 provides additional prognostic insight over standard eGFR evaluations. Due to the critically low number of events, these findings are strictly hypothesis-generating. This exploratory composite score may aid in identifying a highly vulnerable patient subgroup, independent of baseline filtration status and global tumor burden, but requires validation in larger cohorts.

11 September 2026
Verified
Conference Paper
Open access
PDF file
AVAndrii Romanovych Vergun
Andrii Romanovych Vergun
OMOksana Volodymyrivna Melnyk
Oksana Volodymyrivna Melnyk
OVOksana Mykhailivna Vergun
Oksana Mykhailivna Vergun
BPBohdan Myronovych Parashchuk
Bohdan Myronovych Parashchuk
OMOksana Mykolaivna Moshchynska
Oksana Mykolaivna Moshchynska
OZOleksandr Oleksiiovych Zaremba
Oleksandr Oleksiiovych Zaremba
Purulent pressure injuries in palliative care represent a complex clinical problem associated with advanced age, severe comorbidity, impaired mobility, tissue hypoperfusion, malnutrition, and a high risk of infectious complications. Their management requires an individualized and multidisciplinary approach combining prevention, surgical treatment, infection control, and supportive care. To establish relationships between the microbiological characteristics and clinical course of complicated purulent pressure injuries and to substantiate principles of complex treatment for stage III–IV pressure ulcer based on current evidence and clinical experience. A retrospective and prospective analysis of complex treatment outcomes was performed in 320 patients managed over a 10-year period. Clinical, laboratory, instrumental, microbiological, and morphological data were analyzed. Surgical interventions, localization, severity of tissue damage, comorbidities, and infectious complications were evaluated. Women predominated (65.0%); mean age was 85 years in women and 72 years in men. Sacrococcygeal lesions accounted for 40.0% of cases, while gangrenous changes were observed in 87.5% and contact osteomyelitis in 39.69%. A total of 1,216 surgical interventions were performed. Sequential surgical sanitation, including drainage, staged necrectomy, and sequestrectomy when indicated, was central to treatment. Microbiological findings demonstrated polymicrobial involvement and the clinical importance of biofilm formation. Systemic antibiotics were reserved for clinically significant invasive infection. Effective management of complicated pressure injuries requires sequential, pathogenetically grounded, and individualized treatment integrating surgical source control, infection management, nutritional support, decompression, and palliative goals of care.